Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001140361-23-043950
Filing Date
2023-09-14
Accepted
2023-09-14 16:16:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 14D9/A ny20010171x7_sc14d9a.htm SC 14D9/A 34494
  Complete submission text file 0001140361-23-043950.txt   36313
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filed by) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88971 | Film No.: 231255273
SIC: 2834 Pharmaceutical Preparations